Paper & Presentations [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-03-30 01:33 (1348 d 19:45 ago) – Posting: # 18622
Views: 8,480

Hi John,

» If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)

[image]Too much absinthe? I guess you mean this goody:

Yu LX, Jiang W, Zhang X, Lionberger R, Makhlouf F, Schuirmann DF, Muldowney L, Chen M-L, Davit B, Conner D, Woodcock J. Novel Bioequivalence Approach for Narrow Thera­peutic Index Drugs. Clin Pharmacol Ther. 2015;97(3):286–91. doi:10.1002/cpt.28.

» Anyhow, Have you looked at this FDA slide presentation before?

Yep. There are others with more background information. Most simulations were performed in R – Donald told me in 2016 that he grew up with APL and finds R difficult… See also this post. The presentations are gone with the wind. Webarchive [image] #1 (June 2017), [image] #2 (July 2017). In #1 navigate to page 51 and in #2 to page 57.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 12 (0 registered, 12 guests [including 4 identified bots]).
Forum time: Tuesday 20:19 CET (Europe/Vienna)

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz